Population
Patients with relapsing-remitting multiple sclerosis
Design
Review
Authors
Loading...
May refine interferon dosing in MS via gene signatures; leaves open prospective validation of clinical efficacy.
This review outlines the receptor-mediated gene activation mechanisms of interferons and their potential relevance to efficacy in multiple sclerosis.
Rudick et al. (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: